Evidence map›Paper›PMID 26526668›Full record

ArticlePhotosynthesis research2016

Crystal structure and biochemical characterization of Chlamydomonas FDX2 reveal two residues that, when mutated, partially confer FDX2 the redox potential and catalytic properties of FDX1.

Marko Boehm, Markus Alahuhta, David W Mulder, Erin A Peden, Hai Long, Roman Brunecky, Vladimir V Lunin, Paul W King, Maria L Ghirardi, Alexandra Dubini

Open access · hybridAbstract read
In one paragraph

Article in Photosynthesis research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Characteristics of RecombinantJournal of microbiology and biotechnology · 2024
    Article
  3. The AlgaInternational journal of molecular sciences · 2023
    Article
  4. Changing the tracks: screening for electron transfer proteins to support hydrogen production.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Association of Ferredoxin:NADPPhotosynthesis research · 2017
    Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Marko BoehmBiosciences Center, National Renewable Energy Laboratory, Mail Stop: 3313, 15013 Denver West Parkway, Golden, CO, 80401, USA.
Markus AlahuhtaBiosciences Center, National Renewable Energy Laboratory, Mail Stop: 3313, 15013 Denver West Parkway, Golden, CO, 80401, USA.
David W MulderBiosciences Center, National Renewable Energy Laboratory, Mail Stop: 3313, 15013 Denver West Parkway, Golden, CO, 80401, USA.
Erin A PedenBiosciences Center, National Renewable Energy Laboratory, Mail Stop: 3313, 15013 Denver West Parkway, Golden, CO, 80401, USA.
Hai LongComputational Science Center, National Renewable Energy Laboratory, 15013 Denver West Parkway, Golden, CO, 80401, USA.
Roman BruneckyBiosciences Center, National Renewable Energy Laboratory, Mail Stop: 3313, 15013 Denver West Parkway, Golden, CO, 80401, USA.
Vladimir V LuninBiosciences Center, National Renewable Energy Laboratory, Mail Stop: 3313, 15013 Denver West Parkway, Golden, CO, 80401, USA.
Paul W KingBiosciences Center, National Renewable Energy Laboratory, Mail Stop: 3313, 15013 Denver West Parkway, Golden, CO, 80401, USA.
Maria L GhirardiBiosciences Center, National Renewable Energy Laboratory, Mail Stop: 3313, 15013 Denver West Parkway, Golden, CO, 80401, USA.
Alexandra DubiniBiosciences Center, National Renewable Energy Laboratory, Mail Stop: 3313, 15013 Denver West Parkway, Golden, CO, 80401, USA. alexdubini@yahoo.com.
National Renewable Energy Laboratory · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The green alga Chlamydomonas reinhardtii contains six plastidic [2Fe2S]-cluster ferredoxins (FDXs), with FDX1 as the predominant isoform under photoautotrophic growth. FDX2 is highly similar to FDX1 and has been shown to interact with specific enzymes (such as nitrite reductase), as well as to share interactors with FDX1, such as the hydrogenases (HYDA), ferredoxin:NAD(P) reductase I (FNR1), and pyruvate:ferredoxin oxidoreductase (PFR1), albeit performing at low catalytic rates. Here we report the FDX2 crystal structure solved at 1.18 Å resolution. Based on differences between the Chlorella fusca FDX1 and C. reinhardtii FDX2 structures, we generated and purified point-mutated versions of the FDX2 protein and assayed them in vitro for their ability to catalyze hydrogen and NADPH photo-production. The data show that structural differences at two amino acid positions contribute to functional differences between FDX1 and FDX2, suggesting that FDX2 might have evolved from FDX1 toward a different physiological role in the cell. Moreover, we demonstrate that the mutations affect both the midpoint potentials of the FDX and kinetics of the FNR reaction, possibly due to altered binding between FDX and FNR. An effect on H2 photo-production rates was also observed, although the kinetics of the reaction were not further characterized.

Indexed as

Binding SitesCatalytic DomainChlamydomonas reinhardtiiCrystallography, X-RayEscherichia coliFerredoxin-NADP ReductaseFerredoxinsHydrogenModels, MolecularMutagenesis, Site-DirectedNADPOxidation-ReductionPlant ProteinsSequence Homology, Amino AcidStructural Homology, ProteinFerredoxin-NADP ReductaseFerredoxinsHydrogenNADPPlant ProteinsChlamydomonasFerredoxinHydrogen photo-productionInteractionNADPHStructure

Identifiers

PMID26526668
PMCPMC4791469
OpenAlexW1954557240

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.